HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population.

Abstract
Polymorphisms of prion protein gene (PRNP) at codons 129 and 219 play an important role in the susceptibility to Creutzfeldt-Jakob disease (CJD). Alzheimer's disease (AD) and prion diseases, such as CJD, are both characterized by the accumulation of abnormally folded proteins in the brain. An association between sporadic AD and the PRNP polymorphism at codon 129 has been reported in several studies, but other studies have failed to confirm an association. To investigate whether PRNP polymorphisms are associated with an increased risk for developing sporadic AD in the Korean population, we compared the genotype, allele, and haplotype frequencies of PRNP polymorphisms in 271 sporadic AD patients with those in 236 healthy Koreans. Our study does not show a significant difference in PRNP genotype, allele, and haplotype frequency at codons 129 and 219 between sporadic AD and normal controls. Analyses stratifying by age at disease onset, and gender also failed to reveal any association between these polymorphisms and sporadic AD. These results indicate that these PRNP polymorphisms have no direct influence on the susceptibility to sporadic AD in the Korean population.
AuthorsB-H Jeong, K-H Lee, Y-E Jeong, K-A Hwang, Y-J Lee, R I Carp, Y-R Ju, Y-S Kim
JournalEuropean journal of neurology (Eur J Neurol) Vol. 14 Issue 6 Pg. 621-6 (Jun 2007) ISSN: 1468-1331 [Electronic] England
PMID17539938 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Prions
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (genetics)
  • Chi-Square Distribution
  • DNA Mutational Analysis (methods)
  • Female
  • Humans
  • Korea
  • Male
  • Polymorphism, Genetic (genetics)
  • Prions (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: